Given that Goldman Sachs is advising the Twitter board on how to go about the bid from Elon Musk has a Sell rating with a price of $30/share, and Elon is offering way more, why are they suddenly backtracking and implementing a poison pill?
I don't really care if Elon buys the company or not, but it seems to me that the deal is a no brainer from a financial perspective, at least from Goldman Sachs point of view?
I don't believe the BoD has a fiduciary duty to the rest of the world to protect ''freedom of speech'' from Elon Musk, only to provide value to shareholders, so what gives?
Leave a Reply